IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 11, 2026, titled "Press Release Financial Results for the quarter and nine months ended 31st December 2025".
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals and Pharmaceuticals has submitted a press release dated February 11, 2026, sharing its financial results for the third quarter (October–December 2025) and the nine-month period of FY26 ending December 31, 2025. This is a standard intimation to the stock exchange announcing that the results have been formally disclosed. The actual revenue, profit, and segment-level numbers would be contained in the attached press release document, which is not part of this filing text. Investors would need to refer to the press release or the detailed financial results filed separately for the full picture.
This filing itself is procedural — it confirms timely disclosure of Q3 FY26 earnings but does not itself move the needle. Any stock reaction will depend on the actual numbers in the press release, especially revenue growth, margins, and year-on-year profit change versus market expectations.